Feature Channels:

Personalized Medicine

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

drug adverse events, Abacavir, Antiviral Drugs, HIV, abacavir hypersensitivity syndrome, Computer Modeling, HLA-B*57:01, Immune Response

Computer Models Could Allow Researchers to Better Understand, Predict Adverse Drug Reactions

abacavir-adverse-reaction.jpg

Computer model shows what happens at the molecular level during severe allergic reactions to abacavir, a common HIV drug

Medicine

Channels:

Study: Wireless Stimulation May Ease Migraine Pain as Well as Drugs

A preliminary study suggests that a new, wireless patch that you wear on your arm may help reduce migraine pain as well as drugs. The study is published in the March 1, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Medicine

Channels:

Superbugs, Antibiotic Resistance, drug pipeline

Expert on Drug Discovery Available to Speak on the WHO List of Superbugs

kinch_350.jpeg

Medicine

Science

Channels:

New TB Drug Candidates Developed From Soil Bacteria

iStock_8256353_LARGE.jpg

A new treatment for tuberculosis (TB) is set to be developed using compounds derived from bacteria that live in soil - according an international collaboration of researchers, including the University of Warwick.

Medicine

Channels:

Endocrinology, Metabolic Diseases, Diabetes, Diabetes Care, Health Care Systems, Pharmacoeconomics, Health Economics

Collaborative Diabetes Clinic Lowers Health Care Costs

diabetes_infographic_hirsch_morello.jpg

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego are running a Diabetes Intensive Medical Management (DIMM) “tune up” clinic for complex type 2 diabetes patients. In a study published in the March 2017 issue of the Journal of Managed Care & Specialty Pharmacy, the researchers report the clinic’s economic benefits, which include an estimated cost avoidance of $5,287 per DIMM clinic patient over three years.

Medicine

Channels:

opioid abuse, Opioid, Epidemic, Chronic Pain, Patient-Centered Outcomes Research Institute

Cedars-Sinai to Study Most Effective Ways for Doctors to Discuss Opioid Use with Patients Suffering From Chronic Pain

Cedars-Sinai investigators are gearing up to study the most effective ways for doctors to discuss opioid use with chronic pain patients in an effort to reduce the impact of pain while curbing overuse of these addictive drugs. The research team has received $2 million from the Patient-Centered Outcomes Research Institute to conduct the study, which will launch in 2017.

Medicine

Channels:

Amyloid, Amyloid Fibrils, Fibrils, Staphylococcus Aureus, Staphylococcus Aureus (Mrsa), Staphylococcus, MRSA, antibiotic resisistance, Antibiotics

Novel Amyloid Structure Could Lead to New Types of Antibiotics

Researchers have discovered unique amyloid fibers used by the highly drug resistant Staphylococcus aureus bacterium (which causes MRSA). The findings could lead to new types of antibiotics with a novel mechanism of action for attacking bacterial toxins.

Medicine

Science

Channels:

Science Exchange Online Marketplace Now Offers Eurofins Services for Drug Development

/PRNewswire/ -- Science Exchange and Eurofins are excited to announce that Eurofins Central Laboratory is now a service provider listed on the Science Exchange marketplace for outsourced research services. This means that pharmaceutical and biotech companies around the world now have faster access to Eurofins's Clinical Testing portfolio, as well as its end-to-end analytical testing solutions from Drug Discovery to Product Testing.

Medicine

Channels:

Precision Medicine, personalized medicine, White House Precision Medicine intitiative, genome medicine, Personalized Therapies, Undiagnosed Diseases

White House Strategist to Lead UAB’s Personalized Medicine Institute

MattMight.jpg

Matthew Might, Ph.D., a renowned computer scientist and strategic leader appointed to the White House Precision Medicine Initiative by former President Barack Obama, has been named the inaugural director of the Hugh Kaul Personalized Medicine Institute at UAB.

Medicine

Channels:

Drugs That Alter Inhibitory Targets Offer Therapeutic Strategies for Autism, Schizophrenia

Researchers at SUNY Downstate recently discovered that an inhibitory brain receptor triggers synaptic pruning in adolescence. Drugs that selectively target these receptors, when administered during adolescence, can alter synapse number, with possible implications for the treatment of autism and schizophrenia.







Chat now!